Company Information & Drug Savings for Rigel Pharmaceuticals Medications
Rigel Pharmaceuticals is a biotechnology company developing small molecule drugs for immune and hematologic disorders. Based in South San Francisco, the company created Tavalisse (fostamatinib), the first oral spleen tyrosine kinase (SYK) inhibitor for chronic immune thrombocytopenia (ITP). Rigel’s research targets diseases involving aberrant immune cell signaling.
How to Contact Rigel Pharmaceuticals
Phone
1-650-624-1100Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
